Tay 2011.

Trial name or title	Transfusion of red cells in hematopoietic stem cell transplantation: the TRIST study
Methods	Randomised clinical trial stratified by centre and type of transplant
Participants	Participants undergoing hematopoietic stem cell transplantation
Interventions	Restrictive (target haemoglobin of 7 g/dL to 9 g/dL) or liberal (target haemoglobin of 9 g/dL to 11 g/dL) RBC transfusion strategy, based on daily haemoglobin values up to 100 days post‐transplant
Outcomes	Feasibility and clinical outcomes including transfusion requirements, transplant‐related mortality, maximum grade of acute graft versus host disease, veno‐occlusive disease, serious infections, Bearman Toxicity Score, bleeding, quality of life, number of hospitalisations, and number of intensive care unit admissions.
Starting date	March 2011
Contact information	Jason Tay, MD Department of Medicine University of Calgary
Notes	‐

Abbreviations

Hb = haemoglobin
 ICU = intensive care unit
 MDS = myelodysplastic syndromes
 QOL = quality of life
 RBC = red blood cells
 TBSA = total body surface area